These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 26733073)
1. Induction of intrinsic and extrinsic apoptosis through oxidative stress in drug-resistant cancer by a newly synthesized Schiff base copper chelate. Banerjee K; Basu S; Das S; Sinha A; Biswas MK; Choudhuri SK Free Radic Res; 2016; 50(4):426-46. PubMed ID: 26733073 [TBL] [Abstract][Full Text] [Related]
2. Targeting the mitochondrial pathway to induce apoptosis/necrosis through ROS by a newly developed Schiff's base to overcome MDR in cancer. Basu S; Ganguly A; Chakraborty P; Sen R; Banerjee K; Chatterjee M; Efferth T; Choudhuri SK Biochimie; 2012 Jan; 94(1):166-83. PubMed ID: 22037022 [TBL] [Abstract][Full Text] [Related]
3. A newly synthesized nickel chelate can selectively target and overcome multidrug resistance in cancer through redox imbalance both in vivo and in vitro. Banerjee K; Biswas MK; Choudhuri SK J Biol Inorg Chem; 2017 Dec; 22(8):1223-1249. PubMed ID: 29063196 [TBL] [Abstract][Full Text] [Related]
4. Redox active copper chelate overcomes multidrug resistance in T-lymphoblastic leukemia cell by triggering apoptosis. Ganguly A; Basu S; Banerjee K; Chakraborty P; Sarkar A; Chatterjee M; Chaudhuri SK Mol Biosyst; 2011 May; 7(5):1701-12. PubMed ID: 21409205 [TBL] [Abstract][Full Text] [Related]
5. A copper chelate induces apoptosis and overcomes multidrug resistance in T-cell acute lymphoblastic leukemia through redox imbalance and inhibition of EGFR/PI3K/Akt expression. Banerjee K; Das S; Sarkar A; Chatterjee M; Biswas J; Choudhuri SK Biomed Pharmacother; 2016 Dec; 84():71-92. PubMed ID: 27639544 [TBL] [Abstract][Full Text] [Related]
6. The role of a Schiff base scaffold, N-(2-hydroxy acetophenone) glycinate-in overcoming multidrug resistance in cancer. Ganguly A; Chakraborty P; Banerjee K; Choudhuri SK Eur J Pharm Sci; 2014 Jan; 51():96-109. PubMed ID: 24044945 [TBL] [Abstract][Full Text] [Related]
7. Overcoming drug-resistant cancer by a newly developed copper chelate through host-protective cytokine-mediated apoptosis. Mookerjee A; Mookerjee Basu J; Dutta P; Majumder S; Bhattacharyya S; Biswas J; Pal S; Mukherjee P; Raha S; Baral RN; Das T; Efferth T; Sa G; Roy S; Choudhuri SK Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4339-49. PubMed ID: 16857809 [TBL] [Abstract][Full Text] [Related]
8. Overcoming multidrug resistance (MDR) in cancer in vitro and in vivo by a quinoline derivative. Ganguly A; Banerjee K; Chakraborty P; Das S; Sarkar A; Hazra A; Banerjee M; Maity A; Chatterjee M; Mondal NB; Choudhuri SK Biomed Pharmacother; 2011 Sep; 65(6):387-94. PubMed ID: 21715129 [TBL] [Abstract][Full Text] [Related]
9. A zinc Schiff base complex inhibits cancer progression both in vivo and in vitro by inducing apoptosis. Banerjee A; Banerjee K; Sinha A; Das S; Majumder S; Majumdar S; Choudhuri SK Environ Toxicol Pharmacol; 2017 Dec; 56():383-392. PubMed ID: 29145169 [TBL] [Abstract][Full Text] [Related]
11. An in vitro and in vivo study of a novel zinc complex, zinc N-(2-hydroxyacetophenone)glycinate to overcome multidrug resistance in cancer. Ghosh RD; Das S; Ganguly A; Banerjee K; Chakraborty P; Sarkar A; Chatterjee M; Nanda A; Pradhan K; Choudhuri SK Dalton Trans; 2011 Nov; 40(41):10873-84. PubMed ID: 21717020 [TBL] [Abstract][Full Text] [Related]
12. DNA binding, cleavage and cytotoxicity studies of three mononuclear Cu(II) chloro-complexes containing N-S donor Schiff base ligands. Parsekar SU; Fernandes J; Banerjee A; Chouhan OP; Biswas S; Singh M; Mishra DP; Kumar M J Biol Inorg Chem; 2018 Dec; 23(8):1331-1349. PubMed ID: 30302601 [TBL] [Abstract][Full Text] [Related]
13. Selective induction of apoptosis in various cancer cells irrespective of drug sensitivity through a copper chelate, copper N-(2 hydroxy acetophenone) glycinate: crucial involvement of glutathione. Chatterjee S; Chakraborty P; Banerjee K; Sinha A; Adhikary A; Das T; Choudhuri SK Biometals; 2013 Jun; 26(3):517-34. PubMed ID: 23733180 [TBL] [Abstract][Full Text] [Related]
14. Structure and biological properties of mixed-ligand Cu(II) Schiff base complexes as potential anticancer agents. Gou Y; Li J; Fan B; Xu B; Zhou M; Yang F Eur J Med Chem; 2017 Jul; 134():207-217. PubMed ID: 28415010 [TBL] [Abstract][Full Text] [Related]
15. Selective induction of oxidative stress in cancer cells via synergistic combinations of agents targeting redox homeostasis. Akladios FN; Andrew SD; Parkinson CJ Bioorg Med Chem; 2015 Jul; 23(13):3097-104. PubMed ID: 26022081 [TBL] [Abstract][Full Text] [Related]
16. Study on potential antitumor mechanism of a novel Schiff base copper(II) complex: synthesis, crystal structure, DNA binding, cytotoxicity and apoptosis induction activity. Qiao X; Ma ZY; Xie CZ; Xue F; Zhang YW; Xu JY; Qiang ZY; Lou JS; Chen GJ; Yan SP J Inorg Biochem; 2011 May; 105(5):728-37. PubMed ID: 21463568 [TBL] [Abstract][Full Text] [Related]
17. Relationship between the antiproliferative properties of Cu(II) complexes with the Schiff base derived from pyridine-2-carboxaldehyde and 5,6-diamino-1,3-dimethyluracil and the redox status mediated by antioxidant defense systems on glioma tumoral cells. Illán-Cabeza NA; Jiménez-Pulido SB; Hueso-Ureña F; Ramírez-Expósito MJ; Martínez-Martos JM; Moreno-Carretero MN J Inorg Biochem; 2020 Jun; 207():111053. PubMed ID: 32193050 [TBL] [Abstract][Full Text] [Related]
18. Targeting mitochondrial cell death pathway to overcome drug resistance with a newly developed iron chelate. Ganguly A; Basu S; Chakraborty P; Chatterjee S; Sarkar A; Chatterjee M; Choudhuri SK PLoS One; 2010 Jun; 5(6):e11253. PubMed ID: 20582168 [TBL] [Abstract][Full Text] [Related]
19. Copper(II) mixed chelate compounds induce apoptosis through reactive oxygen species in neuroblastoma cell line CHP-212. Gutiérrez AG; Vázquez-Aguirre A; García-Ramos JC; Flores-Alamo M; Hernández-Lemus E; Ruiz-Azuara L; Mejía C J Inorg Biochem; 2013 Sep; 126():17-25. PubMed ID: 23727332 [TBL] [Abstract][Full Text] [Related]